| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | UDP-glucose:glycoprotein glucosyltransferase activity | 2.24e-05 | 2 | 95 | 2 | GO:0003980 | |
| GeneOntologyMolecularFunction | modification-dependent protein binding | 5.76e-05 | 206 | 95 | 7 | GO:0140030 | |
| GeneOntologyMolecularFunction | endothelin receptor activity | 6.70e-05 | 3 | 95 | 2 | GO:0004962 | |
| GeneOntologyMolecularFunction | hexosyltransferase activity | 6.70e-05 | 211 | 95 | 7 | GO:0016758 | |
| GeneOntologyMolecularFunction | glycosyltransferase activity | 6.98e-05 | 288 | 95 | 8 | GO:0016757 | |
| GeneOntologyMolecularFunction | ubiquitin-modified protein reader activity | 1.12e-04 | 20 | 95 | 3 | GO:0140036 | |
| GeneOntologyMolecularFunction | carbohydrate binding | 1.16e-04 | 310 | 95 | 8 | GO:0030246 | |
| GeneOntologyMolecularFunction | apolipoprotein A-I binding | 2.22e-04 | 5 | 95 | 2 | GO:0034186 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein reader activity | 2.22e-04 | 25 | 95 | 3 | GO:0140035 | |
| GeneOntologyMolecularFunction | sphingolipid binding | 5.61e-04 | 34 | 95 | 3 | GO:0046625 | |
| GeneOntologyMolecularFunction | volume-sensitive anion channel activity | 7.89e-04 | 9 | 95 | 2 | GO:0005225 | |
| GeneOntologyMolecularFunction | UDP-glycosyltransferase activity | 8.23e-04 | 153 | 95 | 5 | GO:0008194 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 1.37e-03 | 46 | 95 | 3 | GO:0005245 | |
| GeneOntologyBiologicalProcess | leukocyte cell-cell adhesion | SELL RASGRP1 THBS1 SKAP1 VSIG4 SMARCA2 SMARCA4 EXT1 SIRPB1 SIRPA STAT5A | 1.46e-05 | 486 | 95 | 11 | GO:0007159 |
| GeneOntologyBiologicalProcess | response to nitrogen compound | TRIM16 SELL LGMN CACNA1S THBS1 ABCA1 UGGT1 EDEM2 REG3G PRMT1 UGGT2 EXT1 ACE EDNRA RYR1 EDNRB STAT5A ZC3HAV1 | 1.75e-05 | 1272 | 95 | 18 | GO:1901698 |
| GeneOntologyBiologicalProcess | UDP-glucosylation | 2.10e-05 | 2 | 95 | 2 | GO:0097359 | |
| GeneOntologyBiologicalProcess | carbohydrate derivative metabolic process | ADAMTS12 PIGB GALC GALNT2 NDUFA12 NOTUM EPHA2 UGGT1 TET1 EDEM2 UGGT2 EXT1 RENBP RRM2 EDNRA EDNRB STT3A | 4.02e-05 | 1226 | 95 | 17 | GO:1901135 |
| GeneOntologyBiologicalProcess | steroid metabolic process | 5.97e-05 | 376 | 95 | 9 | GO:0008202 | |
| GeneOntologyBiologicalProcess | heparin metabolic process | 6.14e-05 | 17 | 95 | 3 | GO:0030202 | |
| GeneOntologyBiologicalProcess | negative regulation of endocytosis | 6.68e-05 | 92 | 95 | 5 | GO:0045806 | |
| GeneOntologyBiologicalProcess | regulation of cell-cell adhesion | ZDHHC2 RASGRP1 TENM3 SKAP1 VSIG4 SMARCA2 SMARCA4 SIRPB1 SIRPA TNR STAT5A | 7.29e-05 | 580 | 95 | 11 | GO:0022407 |
| GeneOntologyBiologicalProcess | negative regulation of receptor internalization | 7.35e-05 | 18 | 95 | 3 | GO:0002091 | |
| GeneOntologyBiologicalProcess | negative regulation of I-kappaB phosphorylation | 1.25e-04 | 4 | 95 | 2 | GO:1903720 | |
| GeneOntologyBiologicalProcess | regulation of high-density lipoprotein particle assembly | 1.25e-04 | 4 | 95 | 2 | GO:0090107 | |
| GeneOntologyBiologicalProcess | podocyte differentiation | 1.37e-04 | 22 | 95 | 3 | GO:0072112 | |
| GeneOntologyBiologicalProcess | glomerular epithelial cell differentiation | 1.37e-04 | 22 | 95 | 3 | GO:0072311 | |
| GeneOntologyBiologicalProcess | renal filtration cell differentiation | 1.37e-04 | 22 | 95 | 3 | GO:0061318 | |
| GeneOntologyBiologicalProcess | glomerular epithelium development | 1.57e-04 | 23 | 95 | 3 | GO:0072010 | |
| GeneOntologyBiologicalProcess | protein N-linked glycosylation via asparagine | 1.79e-04 | 24 | 95 | 3 | GO:0018279 | |
| GeneOntologyBiologicalProcess | negative regulation of macrophage inflammatory protein 1 alpha production | 2.08e-04 | 5 | 95 | 2 | GO:0071641 | |
| GeneOntologyBiologicalProcess | glycosylation | 2.52e-04 | 270 | 95 | 7 | GO:0070085 | |
| GeneOntologyBiologicalProcess | myeloid leukocyte migration | 2.88e-04 | 276 | 95 | 7 | GO:0097529 | |
| GeneOntologyBiologicalProcess | phagocytosis, engulfment | 2.90e-04 | 69 | 95 | 4 | GO:0006911 | |
| GeneOntologyBiologicalProcess | UDP-alpha-D-glucose metabolic process | 3.11e-04 | 6 | 95 | 2 | GO:0006011 | |
| GeneOntologyBiologicalProcess | aortic smooth muscle cell differentiation | 3.11e-04 | 6 | 95 | 2 | GO:0035887 | |
| GeneOntologyBiologicalProcess | regulation of cell adhesion | ZDHHC2 RASGRP1 THBS1 TENM3 EPHA2 SKAP1 VSIG4 SMARCA2 SMARCA4 SIRPB1 SIRPA TNR STAT5A | 3.22e-04 | 927 | 95 | 13 | GO:0030155 |
| GeneOntologyBiologicalProcess | ossification involved in bone maturation | 3.51e-04 | 30 | 95 | 3 | GO:0043931 | |
| GeneOntologyBiologicalProcess | multicellular organismal reproductive process | GMCL1 GMCL2 NANOS2 EED SBF1 SMARCA2 LRRC8A CDY2A ACE EDNRA EDNRB STAT5A DNAH1 CDY1 CFAP65 | 3.53e-04 | 1194 | 95 | 15 | GO:0048609 |
| GeneOntologyBiologicalProcess | germ cell development | 3.83e-04 | 482 | 95 | 9 | GO:0007281 | |
| GeneOntologyBiologicalProcess | import into cell | ANKRD13D ANKRD13B ANKRD13A LRRC8C CACNA1D MRC1 CACNA1S THBS1 GAPVD1 ABCA1 LRRC8A SIRPB1 SIRPA LEPR | 3.92e-04 | 1074 | 95 | 14 | GO:0098657 |
| GeneOntologyBiologicalProcess | cell-cell adhesion | ZDHHC2 SELL RASGRP1 THBS1 TENM3 SKAP1 VSIG4 SMARCA2 SMARCA4 EXT1 SIRPB1 SIRPA TNR STAT5A | 4.03e-04 | 1077 | 95 | 14 | GO:0098609 |
| GeneOntologyBiologicalProcess | plasma membrane invagination | 4.64e-04 | 78 | 95 | 4 | GO:0099024 | |
| GeneOntologyBiologicalProcess | bone maturation | 4.67e-04 | 33 | 95 | 3 | GO:0070977 | |
| GeneOntologyBiologicalProcess | positive regulation of immune system process | SELL LGMN RASGRP1 THBS1 CD101 SKAP1 VSIG4 SMARCA2 SMARCA4 REG3G SIRPB1 SIRPA EDNRA STAT5A ZC3HAV1 | 5.34e-04 | 1242 | 95 | 15 | GO:0002684 |
| GeneOntologyBiologicalProcess | gamete generation | GMCL1 GMCL2 NANOS2 EED SBF1 SMARCA2 LRRC8A CDY2A ACE EDNRA DNAH1 CDY1 CFAP65 | 5.56e-04 | 982 | 95 | 13 | GO:0007276 |
| GeneOntologyBiologicalProcess | cyclic-GMP-AMP transmembrane import across plasma membrane | 5.77e-04 | 8 | 95 | 2 | GO:0140361 | |
| GeneOntologyBiologicalProcess | renal albumin absorption | 5.77e-04 | 8 | 95 | 2 | GO:0097018 | |
| GeneOntologyBiologicalProcess | regulation of macrophage inflammatory protein 1 alpha production | 5.77e-04 | 8 | 95 | 2 | GO:0071640 | |
| GeneOntologyBiologicalProcess | alkanesulfonate transmembrane transport | 5.77e-04 | 8 | 95 | 2 | GO:0042918 | |
| GeneOntologyBiologicalProcess | taurine transmembrane transport | 5.77e-04 | 8 | 95 | 2 | GO:0015734 | |
| GeneOntologyBiologicalProcess | lipoprotein metabolic process | 5.95e-04 | 147 | 95 | 5 | GO:0042157 | |
| GeneOntologyBiologicalProcess | spermatogenesis | GMCL1 GMCL2 NANOS2 SBF1 SMARCA2 LRRC8A CDY2A ACE DNAH1 CDY1 CFAP65 | 6.21e-04 | 744 | 95 | 11 | GO:0007283 |
| GeneOntologyBiologicalProcess | cellular extravasation | 6.43e-04 | 85 | 95 | 4 | GO:0045123 | |
| GeneOntologyBiologicalProcess | animal organ maturation | 6.57e-04 | 37 | 95 | 3 | GO:0048799 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte cell-cell adhesion | 6.60e-04 | 317 | 95 | 7 | GO:1903039 | |
| GeneOntologyBiologicalProcess | membrane invagination | 7.02e-04 | 87 | 95 | 4 | GO:0010324 | |
| GeneOntologyBiologicalProcess | negative regulation of chemokine production | 7.10e-04 | 38 | 95 | 3 | GO:0032682 | |
| GeneOntologyBiologicalProcess | cellular process involved in reproduction in multicellular organism | 7.26e-04 | 527 | 95 | 9 | GO:0022412 | |
| GeneOntologyBiologicalProcess | neuroblast migration | 7.40e-04 | 9 | 95 | 2 | GO:0097402 | |
| GeneOntologyBiologicalProcess | protein hexamerization | 7.40e-04 | 9 | 95 | 2 | GO:0034214 | |
| GeneOntologyBiologicalProcess | negative regulation of chemokine (C-C motif) ligand 5 production | 7.40e-04 | 9 | 95 | 2 | GO:0071650 | |
| GeneOntologyBiologicalProcess | macrophage inflammatory protein-1 alpha production | 7.40e-04 | 9 | 95 | 2 | GO:0071608 | |
| GeneOntologyBiologicalProcess | male gamete generation | GMCL1 GMCL2 NANOS2 SBF1 SMARCA2 LRRC8A CDY2A ACE DNAH1 CDY1 CFAP65 | 7.56e-04 | 762 | 95 | 11 | GO:0048232 |
| GeneOntologyBiologicalProcess | negative regulation of receptor-mediated endocytosis | 8.26e-04 | 40 | 95 | 3 | GO:0048261 | |
| GeneOntologyBiologicalProcess | glycoprotein metabolic process | 8.35e-04 | 430 | 95 | 8 | GO:0009100 | |
| GeneOntologyBiologicalProcess | cellular response to oxygen-containing compound | CACNA1D MRC1 LGMN THBS1 ABCA1 TET1 SMARCA4 PRMT1 SIRPB1 SIRPA ACE LEPR EDNRA RYR1 EDNRB STAT5A | 9.11e-04 | 1450 | 95 | 16 | GO:1901701 |
| GeneOntologyBiologicalProcess | guanine nucleotide transmembrane transport | 9.22e-04 | 10 | 95 | 2 | GO:1903790 | |
| GeneOntologyBiologicalProcess | regulation of I-kappaB phosphorylation | 9.22e-04 | 10 | 95 | 2 | GO:1903719 | |
| GeneOntologyBiologicalProcess | outflow tract morphogenesis | 9.38e-04 | 94 | 95 | 4 | GO:0003151 | |
| GeneOntologyBiologicalProcess | fluid transport | 9.54e-04 | 42 | 95 | 3 | GO:0042044 | |
| GeneOntologyBiologicalProcess | inflammatory response | ADAMTS12 IL10RB ATRN RASGRP1 THBS1 EPHA2 REG3G EXT1 SIRPB1 SIRPA LXN EDNRB STAT5A | 9.72e-04 | 1043 | 95 | 13 | GO:0006954 |
| GeneOntologyBiologicalProcess | negative regulation of JNK cascade | 1.02e-03 | 43 | 95 | 3 | GO:0046329 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte cell-cell adhesion | 1.07e-03 | 447 | 95 | 8 | GO:1903037 | |
| GeneOntologyBiologicalProcess | macromolecule glycosylation | 1.10e-03 | 252 | 95 | 6 | GO:0043413 | |
| GeneOntologyBiologicalProcess | protein glycosylation | 1.10e-03 | 252 | 95 | 6 | GO:0006486 | |
| GeneOntologyBiologicalProcess | leukocyte migration | 1.10e-03 | 449 | 95 | 8 | GO:0050900 | |
| GeneOntologyBiologicalProcess | cyclic nucleotide transport | 1.12e-03 | 11 | 95 | 2 | GO:0070729 | |
| GeneOntologyBiologicalProcess | guanine nucleotide transport | 1.12e-03 | 11 | 95 | 2 | GO:0001408 | |
| GeneOntologyBiologicalProcess | cellular response to caffeine | 1.12e-03 | 11 | 95 | 2 | GO:0071313 | |
| GeneOntologyBiologicalProcess | smooth muscle cell differentiation | 1.14e-03 | 99 | 95 | 4 | GO:0051145 | |
| GeneOntologyBiologicalProcess | bone growth | 1.17e-03 | 45 | 95 | 3 | GO:0098868 | |
| GeneOntologyBiologicalProcess | mononuclear cell migration | 1.24e-03 | 258 | 95 | 6 | GO:0071674 | |
| GeneOntologyBiologicalProcess | response to glucose | 1.29e-03 | 260 | 95 | 6 | GO:0009749 | |
| GeneOntologyBiologicalProcess | epithelial cell differentiation involved in kidney development | 1.33e-03 | 47 | 95 | 3 | GO:0035850 | |
| GeneOntologyBiologicalProcess | tissue remodeling | 1.34e-03 | 262 | 95 | 6 | GO:0048771 | |
| GeneOntologyBiologicalProcess | renal protein absorption | 1.34e-03 | 12 | 95 | 2 | GO:0097017 | |
| GeneOntologyBiologicalProcess | positive regulation of natural killer cell differentiation | 1.34e-03 | 12 | 95 | 2 | GO:0032825 | |
| GeneOntologyBiologicalProcess | negative regulation of developmental process | ADAMTS12 LGMN THBS1 ABCA1 EPHA2 TET1 RPS6KA6 SMARCA2 SMARCA4 REG3G PRMT1 TNR EDNRB STAT5A | 1.36e-03 | 1220 | 95 | 14 | GO:0051093 |
| GeneOntologyBiologicalProcess | response to lipopolysaccharide | 1.36e-03 | 464 | 95 | 8 | GO:0032496 | |
| GeneOntologyBiologicalProcess | bone development | 1.39e-03 | 264 | 95 | 6 | GO:0060348 | |
| GeneOntologyBiologicalProcess | response to hexose | 1.42e-03 | 265 | 95 | 6 | GO:0009746 | |
| GeneOntologyBiologicalProcess | lipoprotein biosynthetic process | 1.47e-03 | 106 | 95 | 4 | GO:0042158 | |
| GeneOntologyBiologicalProcess | granulocyte migration | 1.47e-03 | 180 | 95 | 5 | GO:0097530 | |
| GeneOntologyBiologicalProcess | developmental process involved in reproduction | GMCL1 GMCL2 NANOS2 EED SBF1 SMARCA2 LRRC8A CDY2A ACE EDNRA STAT5A DNAH1 CDY1 CFAP65 | 1.53e-03 | 1235 | 95 | 14 | GO:0003006 |
| GeneOntologyBiologicalProcess | cellular response to interleukin-12 | 1.58e-03 | 13 | 95 | 2 | GO:0071349 | |
| GeneOntologyBiologicalProcess | high-density lipoprotein particle assembly | 1.58e-03 | 13 | 95 | 2 | GO:0034380 | |
| GeneOntologyBiologicalProcess | monocyte extravasation | 1.58e-03 | 13 | 95 | 2 | GO:0035696 | |
| GeneOntologyBiologicalProcess | endothelin receptor signaling pathway | 1.58e-03 | 13 | 95 | 2 | GO:0086100 | |
| GeneOntologyBiologicalProcess | pharyngeal arch artery morphogenesis | 1.58e-03 | 13 | 95 | 2 | GO:0061626 | |
| GeneOntologyBiologicalProcess | response to monosaccharide | 1.62e-03 | 272 | 95 | 6 | GO:0034284 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte chemotaxis | 1.62e-03 | 109 | 95 | 4 | GO:0002690 | |
| GeneOntologyBiologicalProcess | response to oxidative stress | 1.64e-03 | 478 | 95 | 8 | GO:0006979 | |
| GeneOntologyBiologicalProcess | positive regulation of stem cell population maintenance | 1.68e-03 | 51 | 95 | 3 | GO:1902459 | |
| GeneOntologyBiologicalProcess | sodium ion homeostasis | 1.68e-03 | 51 | 95 | 3 | GO:0055078 | |
| MousePheno | abnormal muscle electrophysiology | 3.01e-05 | 32 | 79 | 4 | MP:0004145 | |
| MousePheno | abnormal spleen weight | 3.44e-05 | 361 | 79 | 10 | MP:0004951 | |
| Domain | ANKRD13 | 5.08e-07 | 4 | 95 | 3 | IPR021832 | |
| Domain | GPCR_chapero_1 | 5.08e-07 | 4 | 95 | 3 | PF11904 | |
| Domain | C_TYPE_LECTIN_1 | 3.28e-06 | 80 | 95 | 6 | PS00615 | |
| Domain | Lectin_C | 4.36e-06 | 84 | 95 | 6 | PF00059 | |
| Domain | CLECT | 4.36e-06 | 84 | 95 | 6 | SM00034 | |
| Domain | C_TYPE_LECTIN_2 | 4.67e-06 | 85 | 95 | 6 | PS50041 | |
| Domain | C-type_lectin-like | 5.00e-06 | 86 | 95 | 6 | IPR001304 | |
| Domain | - | 1.01e-05 | 97 | 95 | 6 | 3.10.100.10 | |
| Domain | C-type_lectin-like/link | 1.13e-05 | 99 | 95 | 6 | IPR016186 | |
| Domain | CTDL_fold | 1.76e-05 | 107 | 95 | 6 | IPR016187 | |
| Domain | SnAC | 2.56e-05 | 2 | 95 | 2 | SM01314 | |
| Domain | Endthln_rcpt | 2.56e-05 | 2 | 95 | 2 | IPR000499 | |
| Domain | Gln-Leu-Gln_QLQ | 2.56e-05 | 2 | 95 | 2 | IPR014978 | |
| Domain | SnAC | 2.56e-05 | 2 | 95 | 2 | IPR029295 | |
| Domain | UDP-g_GGtrans | 2.56e-05 | 2 | 95 | 2 | IPR009448 | |
| Domain | SnAC | 2.56e-05 | 2 | 95 | 2 | PF14619 | |
| Domain | QLQ | 2.56e-05 | 2 | 95 | 2 | SM00951 | |
| Domain | QLQ | 2.56e-05 | 2 | 95 | 2 | PS51666 | |
| Domain | QLQ | 2.56e-05 | 2 | 95 | 2 | PF08880 | |
| Domain | UDP-g_GGTase | 2.56e-05 | 2 | 95 | 2 | PF06427 | |
| Domain | Crotonase_core_superfam | 8.23e-05 | 17 | 95 | 3 | IPR001753 | |
| Domain | ECH_1 | 8.23e-05 | 17 | 95 | 3 | PF00378 | |
| Domain | UIM | 9.84e-05 | 18 | 95 | 3 | PF02809 | |
| Domain | HSA | 1.53e-04 | 4 | 95 | 2 | SM00573 | |
| Domain | VDCC_L_a1su | 1.53e-04 | 4 | 95 | 2 | IPR005446 | |
| Domain | HSA | 1.53e-04 | 4 | 95 | 2 | PS51204 | |
| Domain | HSA_dom | 1.53e-04 | 4 | 95 | 2 | IPR014012 | |
| Domain | HSA | 1.53e-04 | 4 | 95 | 2 | PF07529 | |
| Domain | UIM | 1.59e-04 | 21 | 95 | 3 | SM00726 | |
| Domain | UIM | 2.39e-04 | 24 | 95 | 3 | PS50330 | |
| Domain | EGF_extracell | 2.46e-04 | 60 | 95 | 4 | IPR013111 | |
| Domain | EGF_2 | 2.46e-04 | 60 | 95 | 4 | PF07974 | |
| Domain | LRRC8_Pannexin-like | 2.53e-04 | 5 | 95 | 2 | IPR021040 | |
| Domain | Pannexin_like | 2.53e-04 | 5 | 95 | 2 | PF12534 | |
| Domain | UIM_dom | 2.70e-04 | 25 | 95 | 3 | IPR003903 | |
| Domain | Chromo | 3.04e-04 | 26 | 95 | 3 | PF00385 | |
| Domain | EGF-like_CS | 3.73e-04 | 261 | 95 | 7 | IPR013032 | |
| Domain | BRK | 3.79e-04 | 6 | 95 | 2 | SM00592 | |
| Domain | BRK_domain | 3.79e-04 | 6 | 95 | 2 | IPR006576 | |
| Domain | BRK | 3.79e-04 | 6 | 95 | 2 | PF07533 | |
| Domain | CHROMO_1 | 3.81e-04 | 28 | 95 | 3 | PS00598 | |
| Domain | CHROMO_2 | 3.81e-04 | 28 | 95 | 3 | PS50013 | |
| Domain | EGF_2 | 4.08e-04 | 265 | 95 | 7 | PS01186 | |
| Domain | VDCC_a1su_IQ | 5.29e-04 | 7 | 95 | 2 | IPR014873 | |
| Domain | GPHH | 5.29e-04 | 7 | 95 | 2 | PF16905 | |
| Domain | GPHH_dom | 5.29e-04 | 7 | 95 | 2 | IPR031649 | |
| Domain | Ca_chan_IQ | 5.29e-04 | 7 | 95 | 2 | SM01062 | |
| Domain | Ca_chan_IQ | 5.29e-04 | 7 | 95 | 2 | PF08763 | |
| Domain | Chromodomain-like | 5.68e-04 | 32 | 95 | 3 | IPR016197 | |
| Domain | IGv | 5.79e-04 | 75 | 95 | 4 | SM00406 | |
| Domain | Chromo/shadow_dom | 6.23e-04 | 33 | 95 | 3 | IPR000953 | |
| Domain | CHROMO | 6.23e-04 | 33 | 95 | 3 | SM00298 | |
| Domain | - | 7.75e-04 | 81 | 95 | 4 | 3.90.550.10 | |
| Domain | Nucleotide-diphossugar_trans | 1.06e-03 | 88 | 95 | 4 | IPR029044 | |
| Domain | VDCCAlpha1 | 1.12e-03 | 10 | 95 | 2 | IPR002077 | |
| Domain | Chromo_dom_subgr | 1.12e-03 | 10 | 95 | 2 | IPR017984 | |
| Domain | EGF_3 | 1.27e-03 | 235 | 95 | 6 | PS50026 | |
| Domain | EGF | 1.27e-03 | 235 | 95 | 6 | SM00181 | |
| Domain | C-type_lectin_CS | 1.36e-03 | 43 | 95 | 3 | IPR018378 | |
| Domain | EGF-like_dom | 1.71e-03 | 249 | 95 | 6 | IPR000742 | |
| Domain | EGF_1 | 1.93e-03 | 255 | 95 | 6 | PS00022 | |
| Domain | Ion_trans_dom | 2.74e-03 | 114 | 95 | 4 | IPR005821 | |
| Domain | Ion_trans | 2.74e-03 | 114 | 95 | 4 | PF00520 | |
| Domain | Channel_four-helix_dom | 3.06e-03 | 57 | 95 | 3 | IPR027359 | |
| Domain | - | 3.06e-03 | 57 | 95 | 3 | 1.20.120.350 | |
| Domain | TSP_1 | 4.06e-03 | 63 | 95 | 3 | PF00090 | |
| Domain | TSP1 | 4.43e-03 | 65 | 95 | 3 | SM00209 | |
| Domain | TSP1_rpt | 4.43e-03 | 65 | 95 | 3 | IPR000884 | |
| Domain | TSP1 | 4.43e-03 | 65 | 95 | 3 | PS50092 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | ATRN LRRC8C LGMN MBTPS1 THBS1 GALNT2 TENM3 EPHA2 UGGT1 EDEM2 OSBPL9 LRRC8A PRMT1 UGGT2 EXT1 GLB1L2 TMEM231 STT3A | 3.87e-09 | 1201 | 95 | 18 | 35696571 |
| Pubmed | 3.04e-08 | 250 | 95 | 9 | 18660489 | ||
| Pubmed | 1.97e-07 | 5 | 95 | 3 | 26797118 | ||
| Pubmed | 1.97e-07 | 5 | 95 | 3 | 24511121 | ||
| Pubmed | 3.93e-07 | 6 | 95 | 3 | 22298428 | ||
| Pubmed | Activation of ATP-binding cassette transporter A1 transcription by chromatin remodeling complex. | 3.93e-07 | 6 | 95 | 3 | 15774904 | |
| Pubmed | 5.57e-07 | 257 | 95 | 8 | 16335952 | ||
| Pubmed | Pharmacogenetic analysis of lipid responses to rosuvastatin in Chinese patients. | 1.07e-06 | 66 | 95 | 5 | 20679960 | |
| Pubmed | Functional analysis of secreted and transmembrane proteins critical to mouse development. | 1.55e-06 | 31 | 95 | 4 | 11431694 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | ANKRD13A GAPVD1 GALNT2 NDUFA12 SERINC1 IARS1 EPHA2 MTX3 UGGT2 GPRC5C ADGRL2 URGCP STT3A | 1.75e-06 | 942 | 95 | 13 | 31073040 |
| Pubmed | ARID1a-DNA interactions are required for promoter occupancy by SWI/SNF. | 2.34e-06 | 10 | 95 | 3 | 23129809 | |
| Pubmed | 5.54e-06 | 13 | 95 | 3 | 18303019 | ||
| Pubmed | FAM105A/OTULINL Is a Pseudodeubiquitinase of the OTU-Class that Localizes to the ER Membrane. | LRRC8C NDUFA12 UGGT1 LRRC8A UGGT2 NUP42 ADGRL2 PLEKHA8 ZC3HAV1 | 5.66e-06 | 468 | 95 | 9 | 31056421 |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 8670841 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 12954602 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 23163725 | ||
| Pubmed | Endothelin receptor heteromerization inhibits β-arrestin function in HEK293 cells. | 7.38e-06 | 2 | 95 | 2 | 32744876 | |
| Pubmed | Identification of a novel role for endothelins within the oviduct. | 7.38e-06 | 2 | 95 | 2 | 20357223 | |
| Pubmed | Investigating the genetic susceptibility to exertional heat illness. | 7.38e-06 | 2 | 95 | 2 | 32054689 | |
| Pubmed | Expression of endothelin receptors in frog, chicken, mouse and human pigment cells. | 7.38e-06 | 2 | 95 | 2 | 16962346 | |
| Pubmed | Combined gene dosage requirement for SWI/SNF catalytic subunits during early mammalian development. | 7.38e-06 | 2 | 95 | 2 | 23076393 | |
| Pubmed | The expression of endothelin type A and B receptors in the lateral wall of the mouse cochlea. | 7.38e-06 | 2 | 95 | 2 | 17607529 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 10694380 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 15576411 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 22532369 | ||
| Pubmed | Mouse germ cell-less as an essential component for nuclear integrity. | 7.38e-06 | 2 | 95 | 2 | 12556490 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 21575570 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 15240517 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 26564006 | ||
| Pubmed | SMARCA4/SMARCA2-deficient Carcinoma of the Esophagus and Gastroesophageal Junction. | 7.38e-06 | 2 | 95 | 2 | 33027072 | |
| Pubmed | Absence of ion channels CACN1AS and SCN4A mutations in thyrotoxic hypokalemic periodic paralysis. | 7.38e-06 | 2 | 95 | 2 | 15072700 | |
| Pubmed | [PRMT1 inhibits apoptosis of nasopharyngeal carcinoma cells by promoting RRM2 expression]. | 7.38e-06 | 2 | 95 | 2 | 36651245 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 23872584 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 12496092 | ||
| Pubmed | Expression of endothelin receptor subtypes in bronchial tumors. | 7.38e-06 | 2 | 95 | 2 | 20043107 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 24582810 | ||
| Pubmed | Alterations of the SWI/SNF chromatin remodelling subunit-BRG1 and BRM in hepatocellular carcinoma. | 7.38e-06 | 2 | 95 | 2 | 23088494 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 37468098 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 21248738 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 24013571 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 20333683 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 34812766 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 14636059 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 25735680 | ||
| Pubmed | Targeting of BRM Sensitizes BRG1-Mutant Lung Cancer Cell Lines to Radiotherapy. | 7.38e-06 | 2 | 95 | 2 | 30478150 | |
| Pubmed | Mutation analysis of CACNA1S and SCN4A in patients with hypokalemic periodic paralysis. | 7.38e-06 | 2 | 95 | 2 | 26252573 | |
| Pubmed | Endothelin ETA and ETB receptor expression in the human trigeminal ganglion. | 7.38e-06 | 2 | 95 | 2 | 16816835 | |
| Pubmed | Functional expression of transgenic 1sDHPR channels in adult mammalian skeletal muscle fibres. | 7.38e-06 | 2 | 95 | 2 | 21262876 | |
| Pubmed | Association between migraine and endothelin type A receptor (ETA -231 A/G) gene polymorphism. | 7.38e-06 | 2 | 95 | 2 | 11376172 | |
| Pubmed | Molecular characterization and regulation of the human endothelin receptors. | 7.38e-06 | 2 | 95 | 2 | 8440682 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 22688668 | ||
| Pubmed | ETA and ETB receptors are expressed in vascular adventitial fibroblasts. | 7.38e-06 | 2 | 95 | 2 | 21949113 | |
| Pubmed | Voltage sensor charge loss accounts for most cases of hypokalemic periodic paralysis. | 7.38e-06 | 2 | 95 | 2 | 19118277 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 19299580 | ||
| Pubmed | The SWI/SNF ATPases Are Required for Triple Negative Breast Cancer Cell Proliferation. | 7.38e-06 | 2 | 95 | 2 | 25808524 | |
| Pubmed | Antagonistic roles for BRM and BRG1 SWI/SNF complexes in differentiation. | 7.38e-06 | 2 | 95 | 2 | 19144648 | |
| Pubmed | Increasing the number of diagnostic mutations in malignant hyperthermia. | 7.38e-06 | 2 | 95 | 2 | 19191329 | |
| Pubmed | Cholesterol homeostasis in ABCA1/LCAT double-deficient mouse. | 7.38e-06 | 2 | 95 | 2 | 19729076 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 28330618 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 9199552 | ||
| Pubmed | Elevation of blood pressure by genetic and pharmacological disruption of the ETB receptor in mice. | 7.38e-06 | 2 | 95 | 2 | 10198387 | |
| Pubmed | Increased gene expression and production of murine endothelin receptors after birth. | 7.38e-06 | 2 | 95 | 2 | 12763050 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 1291713 | ||
| Pubmed | Mechanisms Responsible for ω-Pore Currents in Cav Calcium Channel Voltage-Sensing Domains. | 7.38e-06 | 2 | 95 | 2 | 28978442 | |
| Pubmed | High expression of SMARCA4 or SMARCA2 is frequently associated with an opposite prognosis in cancer. | 7.38e-06 | 2 | 95 | 2 | 29391527 | |
| Pubmed | High density lipoproteins mediate in vivo protection against staphylococcal phenol-soluble modulins. | 7.38e-06 | 2 | 95 | 2 | 34321507 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 10448096 | ||
| Pubmed | Down-regulation of ETA receptors in ETB receptor-deficient mice. | 7.38e-06 | 2 | 95 | 2 | 15838300 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 37634210 | ||
| Pubmed | Adrenal Function in females with low plasma HDL-C due to mutations in ABCA1 and LCAT. | 7.38e-06 | 2 | 95 | 2 | 24842300 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 15838311 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 22365955 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 33320095 | ||
| Pubmed | Endothelin receptor pharmacology and function in the mouse: comparison with rat and man. | 7.38e-06 | 2 | 95 | 2 | 15838332 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 15838285 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 31039173 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 34608571 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 15838254 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 27496766 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 35509066 | ||
| Pubmed | Genotype and phenotype analysis of patients with sporadic periodic paralysis. | 7.38e-06 | 2 | 95 | 2 | 21841462 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 8208605 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 24756152 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 12875994 | ||
| Pubmed | A Brg1 null mutation in the mouse reveals functional differences among mammalian SWI/SNF complexes. | 7.38e-06 | 2 | 95 | 2 | 11163203 | |
| Pubmed | Transcriptional specificity of human SWI/SNF BRG1 and BRM chromatin remodeling complexes. | 7.38e-06 | 2 | 95 | 2 | 12620226 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 27039070 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 29848589 | ||
| Pubmed | Associations of EDNRA and EDNRB Polymorphisms with Intracerebral Hemorrhage. | 7.38e-06 | 2 | 95 | 2 | 31150867 | |
| Pubmed | Facial hyperalgesia due to direct action of endothelin-1 in the trigeminal ganglion of mice. | 7.38e-06 | 2 | 95 | 2 | 29570803 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 23071115 | ||
| Pubmed | Differential preimplantation regulation of two mouse homologues of the yeast SWI2 protein. | 7.38e-06 | 2 | 95 | 2 | 9603422 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 11930911 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 23276717 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 27097303 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 33853662 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 28038711 | ||
| Pubmed | Proinflammatory stimuli engage Brahma related gene 1 and Brahma in endothelial injury. | 7.38e-06 | 2 | 95 | 2 | 23963727 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 12493776 | ||
| Pubmed | Heterozygous Mutations in SMARCA2 Reprogram the Enhancer Landscape by Global Retargeting of SMARCA4. | 7.38e-06 | 2 | 95 | 2 | 31375262 | |
| Interaction | PTPN7 interactions | 6.17e-07 | 65 | 95 | 6 | int:PTPN7 | |
| Cytoband | 17q23.3 | 3.35e-05 | 30 | 95 | 3 | 17q23.3 | |
| Cytoband | 2q31.2 | 8.67e-04 | 21 | 95 | 2 | 2q31.2 | |
| Cytoband | 20p13 | 1.27e-03 | 102 | 95 | 3 | 20p13 | |
| Cytoband | 17q11.2 | 1.58e-03 | 110 | 95 | 3 | 17q11.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q23 | 2.02e-03 | 120 | 95 | 3 | chr17q23 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr20p13 | 2.17e-03 | 123 | 95 | 3 | chr20p13 | |
| GeneFamily | Endothelin receptors | 1.27e-05 | 2 | 65 | 2 | 225 | |
| GeneFamily | UDP-glucose glycoprotein glucosyltransferases | 1.27e-05 | 2 | 65 | 2 | 440 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 1.39e-05 | 41 | 65 | 4 | 1298 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 8.08e-05 | 394 | 65 | 8 | 471 | |
| GeneFamily | Volume regulated anion channel subunits | 1.26e-04 | 5 | 65 | 2 | 1158 | |
| GeneFamily | CD molecules|V-set domain containing|C1-set domain containing|Signal regulatory proteins | 1.26e-04 | 5 | 65 | 2 | 747 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 8.68e-04 | 206 | 65 | 5 | 682 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 2.81e-03 | 163 | 65 | 4 | 590 | |
| GeneFamily | Calcium voltage-gated channel subunits | 3.91e-03 | 26 | 65 | 2 | 253 | |
| Coexpression | MILI_PSEUDOPODIA_CHEMOTAXIS_DN | ATRN LRRC8C LGMN GMCL1 GMCL2 THBS1 SERINC1 EDEM2 OSBPL9 STT3A | 8.10e-06 | 470 | 95 | 10 | MM1053 |
| Coexpression | GSE21360_NAIVE_VS_PRIMARY_MEMORY_CD8_TCELL_UP | 4.05e-05 | 173 | 95 | 6 | M7626 | |
| Coexpression | MILI_PSEUDOPODIA_CHEMOTAXIS_DN | 4.30e-05 | 457 | 95 | 9 | M1613 | |
| Coexpression | GSE6259_33D1_POS_DC_VS_CD4_TCELL_DN | 4.46e-05 | 176 | 95 | 6 | M6757 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_LYMPHATIC_ENDOTHELIAL_CELL | 7.62e-05 | 382 | 95 | 8 | M45756 | |
| Coexpression | GSE2770_UNTREATED_VS_ACT_CD4_TCELL_2H_UP | 8.57e-05 | 198 | 95 | 6 | M6025 | |
| Coexpression | GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY3_DN | 9.05e-05 | 200 | 95 | 6 | M4632 | |
| Coexpression | GSE22140_HEALTHY_VS_ARTHRITIC_GERMFREE_MOUSE_CD4_TCELL_DN | 9.05e-05 | 200 | 95 | 6 | M7646 | |
| Coexpression | GSE15767_MED_VS_SCS_MAC_LN_UP | 9.05e-05 | 200 | 95 | 6 | M3584 | |
| Coexpression | GSE22443_IL2_VS_IL12_TREATED_ACT_CD8_TCELL_DN | 9.05e-05 | 200 | 95 | 6 | M8218 | |
| Coexpression | GSE17721_0.5H_VS_12H_GARDIQUIMOD_BMDC_DN | 9.05e-05 | 200 | 95 | 6 | M4136 | |
| Coexpression | GSE7460_TCONV_VS_TREG_THYMUS_UP | 9.05e-05 | 200 | 95 | 6 | M5675 | |
| Coexpression | DURAND_STROMA_S_UP | 1.12e-04 | 300 | 95 | 7 | M2581 | |
| Coexpression | LI_CISPLATIN_RESISTANCE_UP | 1.13e-04 | 26 | 95 | 3 | M4717 | |
| Coexpression | DURAND_STROMA_S_UP | 1.22e-04 | 304 | 95 | 7 | MM1083 | |
| Coexpression | GSE13762_CTRL_VS_125_VITAMIND_DAY12_DC_DN | 1.30e-04 | 134 | 95 | 5 | M1896 | |
| CoexpressionAtlas | Stromal Cells, LEC.SLN, gp38+ CD31+, Lymph Node, avg-4 | 3.05e-05 | 450 | 94 | 10 | GSM777063_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Pelvic Mesenchyme_emap-8241_top-relative-expression-ranked_500 | 8.87e-05 | 412 | 94 | 9 | gudmap_developingKidney_e15.5_Pelvic Mesenchyme_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Pelvic Mesenchyme_emap-8241_top-relative-expression-ranked_200 | 9.00e-05 | 164 | 94 | 6 | gudmap_developingKidney_e15.5_Pelvic Mesenchyme_200 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k-means-cluster#1_top-relative-expression-ranked_1000 | 9.59e-05 | 240 | 94 | 7 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k1_1000 | |
| CoexpressionAtlas | Myeloid Cells, MF.Thio5.II+480lo.PC, CD115+ MHC II+ F480lo SiglecF- CD11c+, Peritoneal Cavity, avg-3 | 1.14e-04 | 426 | 94 | 9 | GSM605859_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29977_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.23e-04 | 430 | 94 | 9 | DevelopingKidney_e15.5_Endothelial cells_emap-29977_k5_1000 | |
| CoexpressionAtlas | Myeloid Cells, MF.Thio5.II+480int.PC, CD115+ MHC II+ F480lo SiglecF- CD11c+, Peritoneal Cavity, avg-3 | 1.29e-04 | 433 | 94 | 9 | GSM605856_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29977_top-relative-expression-ranked_1000 | ZDHHC2 TRIM16 LRRC8C MRC1 LGMN ABCA1 GALC SIRPB1 SIRPA EDNRB STAT5A ZC3HAV1 | 1.38e-04 | 764 | 94 | 12 | DevelopingKidney_e15.5_Endothelial cells_emap-29977_1000 |
| CoexpressionAtlas | Myeloid Cells, MF.Thio5.II-480int.PC, CD115+ MHCII- F480int SiglecF- CD11c+, Peritoneal Cavity, avg-3 | 1.38e-04 | 437 | 94 | 9 | GSM605865_500 | |
| CoexpressionAtlas | Myeloid Cells, MF.Thio5.II-480hi.PC, CD115+ MHC II- F480hi Siglec F-, Peritoneal Cavity, avg-3 | 1.48e-04 | 441 | 94 | 9 | GSM605862_500 | |
| CoexpressionAtlas | Myeloid Cells, MF.Medl.SLN, CD11b+ CD169+ F4/80+, Lymph Node, avg-2 | 1.87e-04 | 64 | 94 | 4 | GSM854322_100 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Pelvic Mesenchyme_emap-8241_k-means-cluster#4_top-relative-expression-ranked_500 | 2.31e-04 | 195 | 94 | 6 | gudmap_developingKidney_e15.5_Pelvic Mesenchyme_500_k4 | |
| CoexpressionAtlas | Myeloid Cells, Mo.6C+II-.LN, F480+ Ly6c+ MHCII lo/+, Lymph Node, avg-3 | 2.36e-04 | 68 | 94 | 4 | GSM605875_100 | |
| ToppCell | PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.89e-08 | 175 | 95 | 7 | d983e80eeb11f341c564ea684e2b0b585a90ae58 | |
| ToppCell | Macrophages-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 2.06e-07 | 195 | 95 | 7 | eb104f3bb08ab9eca31273c0523a5c90de1f30a9 | |
| ToppCell | wk_20-22-Hematologic-Myeloid-SPP1+_Mac|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.37e-07 | 199 | 95 | 7 | 7c19f1b1f4369edd035ca9cdcf4e653771fc4648 | |
| ToppCell | wk_15-18-Hematologic-Myeloid-SPP1+_Mac|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.37e-07 | 199 | 95 | 7 | c7fc2ac1601346aac71e7620a8a440fde8d92dbd | |
| ToppCell | Bronchial-10x5prime-Immune_Myeloid-Macrophage_other-Macrophage_intravascular|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.45e-07 | 200 | 95 | 7 | ea039de8bd8b325845ce361f84e600c6dad922ed | |
| ToppCell | Severe_COVID-19-Myeloid-MoAM4|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 2.45e-07 | 200 | 95 | 7 | 30448a41ca64d6f0fedaff0b7a6670dd33cdf2c5 | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM4-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.45e-07 | 200 | 95 | 7 | 4f481d87e30195365900acb5d50641a9e7b2f462 | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM4-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.45e-07 | 200 | 95 | 7 | 5490393c5f54748f912676e19b58bd1320415a06 | |
| ToppCell | COVID-19-Myeloid-MoAM2,_CCL18|COVID-19 / Condition, Lineage and Cell class | 2.45e-07 | 200 | 95 | 7 | b0a50622d00335843efad86bc56a1e910019984b | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.45e-07 | 200 | 95 | 7 | cf720d3973e79ffd4c6e763a7284799ced22a274 | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM4|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.45e-07 | 200 | 95 | 7 | df821ac12953e44fcfedbbefb35a4976e406ccd6 | |
| ToppCell | facs-Brain_Myeloid-Cortex_-18m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-06 | 156 | 95 | 6 | 2ba838bc864c2c1767bcab7bb4d790af96b91387 | |
| ToppCell | droplet-Trachea-3m-Hematologic-myeloid-granulocyte-granulocyte_l12-45|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.75e-06 | 170 | 95 | 6 | e028e22ad051c2628248b212b5d28b891e0ee782 | |
| ToppCell | droplet-Bladder-nan-24m-Hematologic-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.14e-06 | 176 | 95 | 6 | 0089b50d607f4d2f18639fab0f3fc779227baa7a | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Interstitial_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-06 | 177 | 95 | 6 | 43883b65b1e03043a24fc40c84c50bac81960c12 | |
| ToppCell | PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.21e-06 | 177 | 95 | 6 | ab92ffc9624850a50c88e6b8f3a517ff2251ff15 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-lung_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-06 | 177 | 95 | 6 | 9de6a82b7fb72d20361947f7ac95bb1fa73fc2ff | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.29e-06 | 178 | 95 | 6 | 0b398656f26c4061b11ccf98908d0e2e1367585a | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.36e-06 | 179 | 95 | 6 | 7ae67e1c09a4ce9b3bcec4c48ee9cf2b1cb4e339 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_A2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.44e-06 | 180 | 95 | 6 | 62511d76d24b836839c3dcc2bf30485ffe9401e2 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_A2|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.60e-06 | 182 | 95 | 6 | 03992d0ae519795239e4f2cc8e63f33c4482de6a | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Endothelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.86e-06 | 185 | 95 | 6 | 512a195ebbae445afe3722a3943020080daf2f3c | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.95e-06 | 186 | 95 | 6 | f73cb91e74a806858650ae97f543fc779ba4cff8 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-Mono-Mono_anti-infl|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.95e-06 | 186 | 95 | 6 | 8694ca16c9780729f4fba67ba20e35745f1eb4e9 | |
| ToppCell | COVID-19-kidney-Fibroblast-1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.04e-06 | 187 | 95 | 6 | 76bfe8c42430a230a8bdf299575c444fb7780f24 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.14e-06 | 188 | 95 | 6 | 5f6ad5d693145d846ca561c2fa55465a88e40b90 | |
| ToppCell | Severe_COVID-19-Epithelial-undefined_Epi|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 3.23e-06 | 189 | 95 | 6 | 8cbd35320c7e7ff013ef0c0f13f8d875db1c53cd | |
| ToppCell | facs-Lung-3m-Endothelial-lymphatic_endothelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.33e-06 | 190 | 95 | 6 | a1514d2186eb4fe569971ab22dc0c17d353fb94a | |
| ToppCell | facs-Lung-3m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.33e-06 | 190 | 95 | 6 | 0bb954a94317cfc742b9b6221bb80f8baa6d3ff1 | |
| ToppCell | 390C-Myeloid-Macrophage|390C / Donor, Lineage, Cell class and subclass (all cells) | 3.33e-06 | 190 | 95 | 6 | f933d971f092c4e56e9f670a9205b688c8b1ca28 | |
| ToppCell | facs-Lung-3m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.33e-06 | 190 | 95 | 6 | 26e2237f65cb43723c5da853831b40df2982d6e4 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.44e-06 | 191 | 95 | 6 | 48823a97c38263f2c6e58348214f5b62773a6368 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.44e-06 | 191 | 95 | 6 | 1caf726bd07fdca389e678fc16304a6ef1790423 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.44e-06 | 191 | 95 | 6 | 3d60c46bced2984c27a1fcf2910bc38b31fb0148 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.44e-06 | 191 | 95 | 6 | 0eedc66e967b1837ce2c14f8c14b3c1eba868c76 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.54e-06 | 192 | 95 | 6 | 4022f208eb5db760abd0aac782a25e8ab63efc64 | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.54e-06 | 192 | 95 | 6 | 5b7093d5af5ae7b0e6d3a464cc56272440ecedad | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.54e-06 | 192 | 95 | 6 | 9333aba0d04203ccccad78d82bf6359922f810a7 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.76e-06 | 194 | 95 | 6 | b1bb0f846d2865efdd9bc8842b16b9d069785882 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.76e-06 | 194 | 95 | 6 | 8deeb3e00237e3d9ad5a1457cd0061576421b9e9 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.76e-06 | 194 | 95 | 6 | b81801fb16e8bd0d6083fe32866051d3c60f3dc7 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.87e-06 | 195 | 95 | 6 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.4.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.99e-06 | 196 | 95 | 6 | eb7d6bbfb766cdeaf5fe0f0bb66a5f491fd5ef26 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.4.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.99e-06 | 196 | 95 | 6 | 173d2c38a01c9ae1c50657d5fc383238aed4aacb | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.99e-06 | 196 | 95 | 6 | 2793ad692d49b3ee78a5cd2d8e0220bf5188a686 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.99e-06 | 196 | 95 | 6 | aae79eafe5bc2c7de16958994a2fe97439d7bea1 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.11e-06 | 197 | 95 | 6 | 85a8f1d18e0dd1d31341f5131eecd217553bf042 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.11e-06 | 197 | 95 | 6 | e8e3ba791dfaa0fab35e0329a5e34376f9ee6143 | |
| ToppCell | 356C-Myeloid-Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 4.11e-06 | 197 | 95 | 6 | 896242e1651435bbc5b6521417e1aca36c215acd | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.4.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.11e-06 | 197 | 95 | 6 | 69671ed173057a67265ac39ed03fbd57dbd22c5c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.11e-06 | 197 | 95 | 6 | 9b480f9c799a244bfee64487abd8a1bf07c9a3a2 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.23e-06 | 198 | 95 | 6 | 6b18e18ed88b6043d6a18bd0f4264ec785781e57 | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_other-Macrophage_intravascular|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.23e-06 | 198 | 95 | 6 | c7dbf24caae5c4ef285845d13055de9e07281bb3 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.23e-06 | 198 | 95 | 6 | 21cf4d81386761d09d0f6829c01c198e5524176d | |
| ToppCell | LPS_only-Myeloid-Dendritic_cells-Monocytes-Macrophages|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.23e-06 | 112 | 95 | 5 | 9801227fe5a6f5ae1b6c5a9e7fa7f35c4c52efe1 | |
| ToppCell | distal-Hematologic-Alveolar_Macrophage-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.35e-06 | 199 | 95 | 6 | 2918967da22602404c767d948fed6c4754e53518 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-myeloid-myeloid_macrophage|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.35e-06 | 199 | 95 | 6 | b827dd8a249f904a0ff930a6c4d3b00fb7bc6fb1 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.35e-06 | 199 | 95 | 6 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Macrophage_other-Macrophage_intravascular|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.35e-06 | 199 | 95 | 6 | 9545ac59c8d75f5747dff86cb511a149dc103b31 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-myeloid-myeloid_macrophage-macrophage|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.35e-06 | 199 | 95 | 6 | c0dcdda30485bb920d3706dcfb06f11b76b6ea37 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.35e-06 | 199 | 95 | 6 | 667b8b47a5b388506e3177b46747267fad8024f6 | |
| ToppCell | wk_08-11-Hematologic-Myeloid-SPP1+_Mac|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 4.35e-06 | 199 | 95 | 6 | d94cf750599366061066074e8007d707adf6fc5a | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Myeloid-Macrophage_other-Macro_CHIT1|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 4.35e-06 | 199 | 95 | 6 | 368e2bafae00ce8e9c6ea480f81b78f96b680acd | |
| ToppCell | Bronchial-10x5prime-Immune_Myeloid-Macrophage_other-Macro_CHIT1|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.35e-06 | 199 | 95 | 6 | 54a54ad983503ed515d476882d86b17d97892037 | |
| ToppCell | COVID-19-kidney-Fibroblast-1|kidney / Disease (COVID-19 only), tissue and cell type | 4.35e-06 | 199 | 95 | 6 | 9503646ff1ad248181146ce767e9d12e882ec3bd | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-mo-Mac|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 4.48e-06 | 200 | 95 | 6 | b3f4eb45545f1632dc62f942756a6b81397c18c1 | |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid-Macrophage_other-Macrophage_intravascular|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.48e-06 | 200 | 95 | 6 | 77a68e8fd97a3f3467d25032067fd7ad52ab8522 | |
| ToppCell | Severe-Myeloid-Macrophages-FCN1-SPP1+|Severe / Condition, Lineage, Cell class and cell subclass | 4.48e-06 | 200 | 95 | 6 | b8cd209b810312793465b28bb2a6cbe5d94da91f | |
| ToppCell | Bronchial-10x5prime-Immune_Myeloid-Macrophage_other|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.48e-06 | 200 | 95 | 6 | 2d2835f97e0ff4f99d384f18e10876575f6bdefd | |
| ToppCell | Posterior_cortex-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-MURAL_Mural.Acta2Rgs5.Abcc9_(Mural.Acta2Rgs5.Abcc9)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 7.53e-06 | 126 | 95 | 5 | 2b06adfb00a557bd90ad93719548a49f9ae9edeb | |
| ToppCell | Posterior_cortex-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-MURAL_Mural.Acta2Rgs5.Abcc9_(Mural.Acta2Rgs5.Abcc9)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 7.53e-06 | 126 | 95 | 5 | 43e7b226a195ab2068518b3a9ffd2192129e8ae4 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_A2|343B / Donor, Lineage, Cell class and subclass (all cells) | 9.80e-06 | 133 | 95 | 5 | 8ff1cf0ea1fc33fe8384c0e65c1ee1853b25a2ae | |
| ToppCell | COVID-19-Heart-CM_5_(RYR2-)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.44e-05 | 144 | 95 | 5 | f92e03dd784e31a9e5dbd4f4c3a6517ea19210cf | |
| ToppCell | 10x5'-blood-Myeloid_Mac|blood / Manually curated celltypes from each tissue | 1.64e-05 | 148 | 95 | 5 | 1ae2d7475e030e2de49940f3287b02953dbf3c65 | |
| ToppCell | 10x5'-blood-Myeloid_Mac-Intermediate_macrophages|blood / Manually curated celltypes from each tissue | 1.64e-05 | 148 | 95 | 5 | b801f38d249a02c4ceceb242cabbbc88418e5fd1 | |
| ToppCell | COVID-19-Heart-CM_5_(RYR2-)|Heart / Disease (COVID-19 only), tissue and cell type | 2.05e-05 | 155 | 95 | 5 | d7e26696fd9c0a759524f331243db43059b33ed9 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.18e-05 | 157 | 95 | 5 | 0966e347f8d32b13f8a3b3afba3f64637c69cdf9 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.18e-05 | 157 | 95 | 5 | 6ebfedd91d62c6d4aa8f046657a899a279f82ba2 | |
| ToppCell | Bac-SEP-Lymphocyte-T_NK-CD4_CTL|Bac-SEP / Disease, Lineage and Cell Type | 2.25e-05 | 158 | 95 | 5 | 4beed58bf58253253fc7e5009294b35e3bb8eae3 | |
| ToppCell | severe_COVID-19-pDC|severe_COVID-19 / disease group, cell group and cell class (v2) | 2.32e-05 | 159 | 95 | 5 | ea5088d27e42b8850455764d53b757ea8d8f14bc | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.54e-05 | 162 | 95 | 5 | ec29c6f1c31e41ddcb041a49c593910edaf0532c | |
| ToppCell | droplet-Marrow-BM-30m-Lymphocytic-plasma_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.69e-05 | 164 | 95 | 5 | 758e85e2f5e7236b345e16c78344d5e0bf17d8dc | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_NK-NK_CD56bright_CD16-|GI_small-bowel / Manually curated celltypes from each tissue | 2.69e-05 | 164 | 95 | 5 | 36e64e4f717dd59b352c20ff9742ca1e232342bb | |
| ToppCell | PND28-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.77e-05 | 165 | 95 | 5 | 47e716ce8dc283d406352c1909e09362fcb9e3a3 | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Lymphocytic-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.77e-05 | 165 | 95 | 5 | 8c7a6f9e2ca0ce077426d3d0726e3f5a4c03b296 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Monocytic-Macrophage-IM|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.77e-05 | 165 | 95 | 5 | fe2135fdacf3807eb4b5ea5e790febfb8cd54335 | |
| ToppCell | droplet-Thymus-nan-21m-Myeloid-Plasma_cells_and_B_cells|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.77e-05 | 165 | 95 | 5 | 21a82a975f550080b6674750b06212205cd16742 | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-Treg|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.02e-05 | 168 | 95 | 5 | c09aa66fd1374ecc4b4d4b56600a6f04aafa5be9 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.11e-05 | 169 | 95 | 5 | 16c52a0f6d96ecc1832922fce9b39691849f0d73 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.11e-05 | 169 | 95 | 5 | 225aec04ba762d4c55885257de03a65b63503fbb | |
| ToppCell | 367C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.11e-05 | 169 | 95 | 5 | 278960f940b646a788360b1c84d641a8d169896b | |
| ToppCell | facs-Diaphragm-Limb_Muscle-18m-Endothelial-new-cluster|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.20e-05 | 170 | 95 | 5 | 4fb4ce46e4fa2418238e264875209d7ebe844d82 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.29e-05 | 171 | 95 | 5 | 972fab891135bd755d5526cbc5a963200067b0a6 | |
| ToppCell | facs-Marrow-B-cells-18m-Lymphocytic-BM_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.29e-05 | 171 | 95 | 5 | 6f49537f8d3cf18e65aa999fec32ed347ce2da3e | |
| ToppCell | facs-Marrow-B-cells-18m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.29e-05 | 171 | 95 | 5 | ab97ae2b127a585f170f028f1c475cdd1b0cdea5 | |
| ToppCell | droplet-Trachea-3m-Hematologic-myeloid-granulocyte-|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.29e-05 | 171 | 95 | 5 | 41932c9e70829ee3d55ca5fdb74d290fc8229416 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.29e-05 | 171 | 95 | 5 | 2a77ed79c6f2e700e789c80451a70ecb31639719 | |
| ToppCell | COVID-19-Heart-T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.29e-05 | 171 | 95 | 5 | b2e753e811a7639956994609f73efcdb62d04f82 | |
| ToppCell | Bronchial_Biopsy-Endothelial-Lymphatic|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.38e-05 | 172 | 95 | 5 | c41f5a66781bbf63afce7ca5d118cc6d8e0fe0bc | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Interstitial_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.47e-05 | 173 | 95 | 5 | 26bba58f9fb215d1d155504906cd77e8774f6936 | |
| Drug | lercanidipine | 2.52e-07 | 63 | 95 | 6 | CID000065866 | |
| Drug | N-cyclopentyl-N-cyclobutylformamide | 9.78e-07 | 79 | 95 | 6 | CID005287890 | |
| Drug | Nchembio861-comp5 | 2.53e-06 | 52 | 95 | 5 | CID004476950 | |
| Drug | CPU0213 | 8.27e-06 | 10 | 95 | 3 | ctd:C513821 | |
| Drug | terazosin | 1.06e-05 | 33 | 95 | 4 | CID000005401 | |
| Drug | AC1L1EDT | 1.20e-05 | 34 | 95 | 4 | CID000002751 | |
| Drug | Bosentan | 1.72e-05 | 2 | 95 | 2 | DB00559 | |
| Drug | TAK 044 | 1.72e-05 | 2 | 95 | 2 | ctd:C088196 | |
| Drug | 6-bromo-2,3-dihydrobenzofuran | 1.72e-05 | 2 | 95 | 2 | CID011252616 | |
| Drug | 1H-Indene-2-carboxylic acid, 1-(1,3-benzodioxol-5-yl)-3-(2- (carboxymethoxy)-4-methoxyphenyl)-2,3-dihydro-5-propoxy-, (1S,2R,3S)- | 1.72e-05 | 2 | 95 | 2 | ctd:C087551 | |
| Drug | IRL 1620 | 1.72e-05 | 2 | 95 | 2 | ctd:C074308 | |
| Drug | enrasentan | 1.72e-05 | 2 | 95 | 2 | ctd:C098288 | |
| Drug | PD 145065 | 1.72e-05 | 2 | 95 | 2 | ctd:C082887 | |
| Drug | LU 224332 | 1.72e-05 | 2 | 95 | 2 | ctd:C113044 | |
| Drug | U973 | 1.72e-05 | 2 | 95 | 2 | CID000010737 | |
| Drug | Sitaxentan | 1.72e-05 | 2 | 95 | 2 | DB06268 | |
| Drug | A 182086 | 1.72e-05 | 2 | 95 | 2 | ctd:C467893 | |
| Drug | PD 156252 | 1.72e-05 | 2 | 95 | 2 | ctd:C106950 | |
| Drug | L-671,776 | 1.72e-05 | 2 | 95 | 2 | CID000122853 | |
| Drug | tezosentan | 1.72e-05 | 2 | 95 | 2 | ctd:C120582 | |
| Drug | spirodihydrobenzofuranlactam VI | 1.72e-05 | 2 | 95 | 2 | CID000469820 | |
| Drug | J 104132 | 1.72e-05 | 2 | 95 | 2 | ctd:C119319 | |
| Drug | auramine | 2.48e-05 | 14 | 95 | 3 | CID000010298 | |
| Drug | FPL 64176 | 3.09e-05 | 15 | 95 | 3 | CID000003423 | |
| Drug | nicardipine | 3.28e-05 | 145 | 95 | 6 | CID000004473 | |
| Drug | N(G)-nitro-L-arginine methyl ester | 3.41e-05 | 146 | 95 | 6 | CID000003864 | |
| Drug | VAL-TYR | 3.79e-05 | 16 | 95 | 3 | CID004065033 | |
| Drug | phosphoramidon | 3.79e-05 | 16 | 95 | 3 | ctd:C008890 | |
| Drug | DuP 532 | 3.79e-05 | 16 | 95 | 3 | CID000060770 | |
| Drug | aldosterone | 4.27e-05 | 397 | 95 | 9 | CID000005839 | |
| Drug | E106E | 5.15e-05 | 3 | 95 | 2 | CID000026761 | |
| Drug | pyrazolinone | 5.15e-05 | 3 | 95 | 2 | CID000351317 | |
| Drug | ZD 2574 | 5.15e-05 | 3 | 95 | 2 | ctd:C415840 | |
| Drug | t964 | 5.15e-05 | 3 | 95 | 2 | CID000066663 | |
| Drug | myriceric acid C | 5.15e-05 | 3 | 95 | 2 | CID005274625 | |
| Drug | WS009A | 5.15e-05 | 3 | 95 | 2 | CID000131948 | |
| Drug | Pd164333 | 5.15e-05 | 3 | 95 | 2 | CID005311351 | |
| Drug | 2-nitrobenzoyl chloride | 5.15e-05 | 3 | 95 | 2 | CID000011875 | |
| Drug | 2-ethylacetanilide | 5.15e-05 | 3 | 95 | 2 | CID000036332 | |
| Drug | NSC 90 | 5.15e-05 | 3 | 95 | 2 | CID000073811 | |
| Drug | KW-3049 | 5.65e-05 | 50 | 95 | 4 | CID000002324 | |
| Drug | nitrendipine | 5.69e-05 | 98 | 95 | 5 | CID000004507 | |
| Drug | sodium chloride | SELL MRC1 PIGB GALC EPHA2 SIRPA GLB1L2 AGPS ADGRL2 ACE EDNRA EDNRB STT3A | 6.16e-05 | 865 | 95 | 13 | CID000000206 |
| Drug | isradipine | 6.26e-05 | 100 | 95 | 5 | CID000003784 | |
| Drug | AC1L1KRB | 7.67e-05 | 54 | 95 | 4 | CID000005621 | |
| Drug | AC1Q5S71 | 7.96e-05 | 170 | 95 | 6 | CID000000501 | |
| Drug | Isoproterenol | SELL LRRC8C MRC1 PIGB ABCA1 REG3G PRMT1 LCAT NEB LEPR EDNRA EDNRB STT3A STAT5A | 7.97e-05 | 1016 | 95 | 14 | ctd:D007545 |
| Drug | UDP-glucose | 7.97e-05 | 247 | 95 | 7 | CID000001166 | |
| Drug | Cinildipine | 8.85e-05 | 56 | 95 | 4 | CID000002752 | |
| Drug | darusentan | 1.02e-04 | 58 | 95 | 4 | CID000177236 | |
| Drug | 4-phenoxybutyric acid | 1.03e-04 | 4 | 95 | 2 | CID000022741 | |
| Drug | sarafotoxins s6 | 1.03e-04 | 4 | 95 | 2 | ctd:C057354 | |
| Drug | indane-2-carboxylic acid | 1.03e-04 | 4 | 95 | 2 | CID000575777 | |
| Drug | Ritodrine hydrochloride [23239-51-2]; Up 200; 12.4uM; PC3; HT_HG-U133A | 1.06e-04 | 179 | 95 | 6 | 4619_UP | |
| Drug | H S Q | 1.12e-04 | 351 | 95 | 8 | CID000000897 | |
| Drug | nilvadipine | 1.16e-04 | 60 | 95 | 4 | CID000004494 | |
| Drug | AC1L1ICD | 1.17e-04 | 23 | 95 | 3 | CID000004516 | |
| Drug | guanosine 3',5'-cyclic monophosphoric acid | CACNA1D CACNA1S NANOS2 EED SMARCA2 SMARCA4 ACE EDNRA RYR1 EDNRB | 1.48e-04 | 577 | 95 | 10 | CID000000295 |
| Drug | mibefradil | 1.49e-04 | 64 | 95 | 4 | CID000060662 | |
| Drug | propofol | 1.51e-04 | 191 | 95 | 6 | CID000004943 | |
| Drug | Butylparaben [94-26-8]; Down 200; 20.6uM; PC3; HT_HG-U133A | 1.51e-04 | 191 | 95 | 6 | 4647_DN | |
| Drug | butenolide | 1.51e-04 | 25 | 95 | 3 | CID000010341 | |
| Drug | 6-keto-prostaglandin F1 alpha | 1.58e-04 | 65 | 95 | 4 | CID000001866 | |
| Drug | dihydropyridine | 1.60e-04 | 193 | 95 | 6 | CID000104822 | |
| Drug | fluo-3 | 1.60e-04 | 122 | 95 | 5 | CID000104978 | |
| Drug | Nisoldipine | 1.71e-04 | 5 | 95 | 2 | DB00401 | |
| Drug | L015040 | 1.71e-04 | 5 | 95 | 2 | CID004574540 | |
| Drug | 2-phenylethenesulfonamide | 1.71e-04 | 5 | 95 | 2 | CID000257501 | |
| Drug | Be 18257a | 1.71e-04 | 5 | 95 | 2 | CID000197302 | |
| Drug | SB 234551 | 1.71e-04 | 5 | 95 | 2 | CID005311425 | |
| Drug | Nilvadipine | 1.71e-04 | 5 | 95 | 2 | DB06712 | |
| Drug | pd 151242 | 1.71e-04 | 5 | 95 | 2 | CID000132991 | |
| Drug | 1,5-dihydroxyisoquinoline | 1.71e-04 | 5 | 95 | 2 | ctd:C095653 | |
| Drug | Et-(16-21) | 1.71e-04 | 5 | 95 | 2 | CID000129432 | |
| Drug | T-1095A | 1.71e-04 | 5 | 95 | 2 | CID006918439 | |
| Drug | butynediol | 1.71e-04 | 5 | 95 | 2 | CID000008066 | |
| Drug | Diphenylpyraline hydrochloride [132-18-3]; Up 200; 12.6uM; PC3; HT_HG-U133A | 1.78e-04 | 197 | 95 | 6 | 4299_UP | |
| Drug | Gliquidone [33342-05-1]; Down 200; 7.6uM; PC3; HT_HG-U133A | 1.78e-04 | 197 | 95 | 6 | 7301_DN | |
| Drug | bepridil | 1.87e-04 | 126 | 95 | 5 | CID000002351 | |
| Drug | Gly-His-Lys acetate salt; Down 200; 1uM; PC3; HT_HG-U133A | 1.88e-04 | 199 | 95 | 6 | 6560_DN | |
| Drug | 2d41 | 1.91e-04 | 27 | 95 | 3 | CID009543496 | |
| Drug | Sch 39370 | 1.91e-04 | 27 | 95 | 3 | CID000121872 | |
| Drug | U46619 | 1.93e-04 | 285 | 95 | 7 | CID000005618 | |
| Drug | 2-aminoethyl diphenylborinate | 1.94e-04 | 127 | 95 | 5 | CID000001598 | |
| Drug | glibenclamide | 1.99e-04 | 382 | 95 | 8 | CID000003488 | |
| Drug | AC1L2AC7 | 2.00e-04 | 69 | 95 | 4 | CID000068733 | |
| Drug | UDP-N-acetylglucosamine | 2.10e-04 | 203 | 95 | 6 | CID000001167 | |
| Drug | AC1L1JVU | 2.35e-04 | 72 | 95 | 4 | CID000005229 | |
| Drug | Bq610 | 2.38e-04 | 29 | 95 | 3 | CID000123905 | |
| Drug | iloprost | 2.48e-04 | 134 | 95 | 5 | CID005311181 | |
| Drug | Bq 153 | 2.56e-04 | 6 | 95 | 2 | CID000196897 | |
| Drug | A-192621 | 2.56e-04 | 6 | 95 | 2 | CID005310991 | |
| Drug | chloro-m-cresol | 2.56e-04 | 6 | 95 | 2 | CID000012008 | |
| Drug | Bq 928 | 2.56e-04 | 6 | 95 | 2 | CID000133071 | |
| Drug | CPU-23 | 2.56e-04 | 6 | 95 | 2 | CID003036051 | |
| Drug | R)-3-pyrrolidinecarboxylic acid | 2.56e-04 | 6 | 95 | 2 | CID001501969 | |
| Drug | Michler's ketone | 2.56e-04 | 6 | 95 | 2 | CID000007031 | |
| Drug | CGS 27830 | 2.56e-04 | 6 | 95 | 2 | CID000190809 | |
| Drug | NSC114784 | 2.56e-04 | 6 | 95 | 2 | CID000419425 | |
| Drug | sulfo-NHS-LC-biotin | 2.91e-04 | 31 | 95 | 3 | CID000130610 | |
| Disease | Congenital myopathy (disorder) | 4.49e-08 | 12 | 93 | 4 | C0270960 | |
| Disease | myocardial infarction (implicated_via_orthology) | 2.14e-06 | 66 | 93 | 5 | DOID:5844 (implicated_via_orthology) | |
| Disease | obstructive sleep apnea (is_implicated_in) | 4.91e-06 | 11 | 93 | 3 | DOID:0050848 (is_implicated_in) | |
| Disease | Malignant hyperthermia, susceptibility to | 9.83e-06 | 2 | 93 | 2 | cv:C5437603 | |
| Disease | Malignant hyperthermia | 9.83e-06 | 2 | 93 | 2 | cv:C5779784 | |
| Disease | level of tyrosine-protein phosphatase non-receptor type substrate 1 in blood serum | 9.83e-06 | 2 | 93 | 2 | OBA_2040362 | |
| Disease | Malignant hyperpyrexia due to anesthesia | 9.83e-06 | 2 | 93 | 2 | C0024591 | |
| Disease | HYPOKALEMIC PERIODIC PARALYSIS, TYPE 1 | 9.83e-06 | 2 | 93 | 2 | 170400 | |
| Disease | Hypokalemic periodic paralysis, type 1 | 9.83e-06 | 2 | 93 | 2 | cv:C3714580 | |
| Disease | Hypokalemic periodic paralysis | 9.83e-06 | 2 | 93 | 2 | cv:C0238358 | |
| Disease | malignant hyperthermia (is_implicated_in) | 2.94e-05 | 3 | 93 | 2 | DOID:8545 (is_implicated_in) | |
| Disease | Hypokalemic periodic paralysis type 1 | 2.94e-05 | 3 | 93 | 2 | C3714580 | |
| Disease | low density lipoprotein cholesterol measurement, lipid measurement | 3.12e-05 | 114 | 93 | 5 | EFO_0004529, EFO_0004611 | |
| Disease | total cholesterol measurement, low density lipoprotein cholesterol measurement | 3.12e-05 | 114 | 93 | 5 | EFO_0004574, EFO_0004611 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 4.21e-05 | 61 | 93 | 4 | EFO_0008317, EFO_0008596, EFO_0020946 | |
| Disease | cholesteryl ester measurement, low density lipoprotein cholesterol measurement | 5.04e-05 | 126 | 93 | 5 | EFO_0004611, EFO_0010351 | |
| Disease | choline measurement | 5.85e-05 | 130 | 93 | 5 | EFO_0010116 | |
| Disease | Timothy syndrome (implicated_via_orthology) | 5.87e-05 | 4 | 93 | 2 | DOID:0060173 (implicated_via_orthology) | |
| Disease | Rare disease with malignant hyperthermia | 5.87e-05 | 4 | 93 | 2 | cv:C5681128 | |
| Disease | Hypokalemic periodic paralysis | 5.87e-05 | 4 | 93 | 2 | C0238358 | |
| Disease | phospholipid measurement | 8.32e-05 | 140 | 93 | 5 | EFO_0004639 | |
| Disease | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement | 9.50e-05 | 144 | 93 | 5 | EFO_0004611, EFO_0020943 | |
| Disease | MENTAL RETARDATION, AUTOSOMAL DOMINANT 12 | 9.77e-05 | 5 | 93 | 2 | C3281201 | |
| Disease | MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE | 1.46e-04 | 6 | 93 | 2 | C1854678 | |
| Disease | obstructive sleep apnea (biomarker_via_orthology) | 2.72e-04 | 8 | 93 | 2 | DOID:0050848 (biomarker_via_orthology) | |
| Disease | hypokalemic periodic paralysis (implicated_via_orthology) | 2.72e-04 | 8 | 93 | 2 | DOID:14452 (implicated_via_orthology) | |
| Disease | Pulmonary Hypertension | 2.75e-04 | 40 | 93 | 3 | C0020542 | |
| Disease | lipoprotein measurement | 3.47e-04 | 105 | 93 | 4 | EFO_0004732 | |
| Disease | opportunistic bacterial infectious disease (implicated_via_orthology) | 3.49e-04 | 9 | 93 | 2 | DOID:0050340 (implicated_via_orthology) | |
| Disease | signal-regulatory protein beta-1 measurement | 3.49e-04 | 9 | 93 | 2 | EFO_0802069 | |
| Disease | free cholesterol to total lipids in small HDL percentage | 5.66e-04 | 51 | 93 | 3 | EFO_0022285 | |
| Disease | low density lipoprotein cholesterol measurement, phospholipid measurement | 5.75e-04 | 120 | 93 | 4 | EFO_0004611, EFO_0004639 | |
| Disease | free cholesterol to total lipids in very large HDL percentage | 7.06e-04 | 55 | 93 | 3 | EFO_0022288 | |
| Disease | docosahexaenoic acid measurement | 7.11e-04 | 127 | 93 | 4 | EFO_0007761 | |
| Disease | triglyceride measurement, very low density lipoprotein cholesterol measurement | 7.29e-04 | 224 | 93 | 5 | EFO_0004530, EFO_0008317 | |
| Disease | hypertension (implicated_via_orthology) | 7.32e-04 | 128 | 93 | 4 | DOID:10763 (implicated_via_orthology) | |
| Disease | triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 7.43e-04 | 225 | 93 | 5 | EFO_0008317, EFO_0020947 | |
| Disease | cholesterol to total lipids in large LDL percentage | 7.44e-04 | 56 | 93 | 3 | EFO_0022235 | |
| Disease | Coffin-Siris syndrome | 7.49e-04 | 13 | 93 | 2 | C0265338 | |
| Disease | COVID-19, coronary artery disease | 7.49e-04 | 13 | 93 | 2 | EFO_0001645, MONDO_0100096 | |
| Disease | free cholesterol in medium HDL measurement | 8.25e-04 | 58 | 93 | 3 | EFO_0022267 | |
| Disease | platelet crit | GMCL2 THBS1 GALNT2 SERINC1 SKAP1 SIRPB1 SIRPA LEPR EDNRA ZC3HAV1 | 8.39e-04 | 952 | 93 | 10 | EFO_0007985 |
| Disease | cholesterol in medium HDL measurement | 8.67e-04 | 59 | 93 | 3 | EFO_0021903 | |
| Disease | free cholesterol to total lipids in medium HDL percentage | 9.11e-04 | 60 | 93 | 3 | EFO_0022282 | |
| Disease | free cholesterol in HDL measurement | 9.56e-04 | 61 | 93 | 3 | EFO_0022264 | |
| Disease | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | 1.05e-03 | 243 | 93 | 5 | EFO_0004612, EFO_0020944 | |
| Disease | total lipids in HDL measurement | 1.05e-03 | 63 | 93 | 3 | EFO_0022307 | |
| Disease | Spermatogenic Failure, Nonobstructive, Y-Linked | 1.15e-03 | 16 | 93 | 2 | C1839071 | |
| Disease | Spermatogenic failure, Y-linked, 2 | 1.15e-03 | 16 | 93 | 2 | cv:C1839071 | |
| Disease | SPERMATOGENIC FAILURE, Y-LINKED, 2 | 1.15e-03 | 16 | 93 | 2 | 415000 | |
| Disease | carotid atherosclerosis | 1.15e-03 | 16 | 93 | 2 | EFO_0009783 | |
| Disease | Renal Insufficiency | 1.30e-03 | 17 | 93 | 2 | C1565489 | |
| Disease | Astrocytosis | 1.30e-03 | 17 | 93 | 2 | C3887640 | |
| Disease | renal fibrosis (implicated_via_orthology) | 1.30e-03 | 17 | 93 | 2 | DOID:0050855 (implicated_via_orthology) | |
| Disease | Gliosis | 1.30e-03 | 17 | 93 | 2 | C0017639 | |
| Disease | low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 1.42e-03 | 153 | 93 | 4 | EFO_0004611, EFO_0020946 | |
| Disease | low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 1.42e-03 | 153 | 93 | 4 | EFO_0004611, EFO_0020944 | |
| Disease | fibrinogen measurement, coronary artery disease | 1.45e-03 | 154 | 93 | 4 | EFO_0001645, EFO_0004623 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 1.51e-03 | 264 | 93 | 5 | EFO_0008317, EFO_0020944 | |
| Disease | phospholipids in large HDL measurement | 1.61e-03 | 73 | 93 | 3 | EFO_0022190 | |
| Disease | portal hypertension (implicated_via_orthology) | 1.62e-03 | 19 | 93 | 2 | DOID:10762 (implicated_via_orthology) | |
| Disease | total lipids in large HDL | 1.67e-03 | 74 | 93 | 3 | EFO_0022189 | |
| Disease | triglyceride measurement, high density lipoprotein cholesterol measurement | 1.78e-03 | 274 | 93 | 5 | EFO_0004530, EFO_0004612 | |
| Disease | end stage renal disease (implicated_via_orthology) | 1.80e-03 | 20 | 93 | 2 | DOID:783 (implicated_via_orthology) | |
| Disease | Schizophrenia | 1.89e-03 | 883 | 93 | 9 | C0036341 | |
| Disease | triglyceride measurement, low density lipoprotein cholesterol measurement | 1.91e-03 | 166 | 93 | 4 | EFO_0004530, EFO_0004611 | |
| Disease | free cholesterol in large HDL measurement | 2.02e-03 | 79 | 93 | 3 | EFO_0022157 | |
| Disease | cholesterol in large HDL measurement | 2.09e-03 | 80 | 93 | 3 | EFO_0021900 | |
| Disease | type 2 diabetes mellitus (is_implicated_in) | 2.13e-03 | 171 | 93 | 4 | DOID:9352 (is_implicated_in) | |
| Disease | Kidney Failure | 2.18e-03 | 22 | 93 | 2 | C0035078 | |
| Disease | age at voice drop | 2.18e-03 | 22 | 93 | 2 | EFO_0007888 | |
| Disease | aspartate aminotransferase measurement | ADAMTS12 MRC1 CACNA1S ABCA1 GALNT2 THSD7A PLEKHA3 EDEM2 LEPR | 2.21e-03 | 904 | 93 | 9 | EFO_0004736 |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 2.31e-03 | 291 | 93 | 5 | EFO_0008317, EFO_0020946 | |
| Disease | Immunologic Deficiency Syndromes | 2.38e-03 | 23 | 93 | 2 | C0021051 | |
| Disease | vitronectin measurement | 2.38e-03 | 23 | 93 | 2 | EFO_0021843 | |
| Disease | lipoprotein measurement, phospholipid measurement | 2.48e-03 | 85 | 93 | 3 | EFO_0004639, EFO_0004732 | |
| Disease | nephrotic syndrome (implicated_via_orthology) | 2.59e-03 | 24 | 93 | 2 | DOID:1184 (implicated_via_orthology) | |
| Disease | Albuminuria | 2.59e-03 | 24 | 93 | 2 | C0001925 | |
| Disease | 3-hydroxybutyrate measurement | 2.81e-03 | 25 | 93 | 2 | EFO_0010982 | |
| Disease | large artery stroke, coronary artery disease | 2.81e-03 | 25 | 93 | 2 | EFO_0001645, EFO_0005524 | |
| Disease | primary biliary cholangitis (is_marker_for) | 2.81e-03 | 25 | 93 | 2 | DOID:12236 (is_marker_for) | |
| Disease | lipid measurement, lipoprotein measurement | 2.92e-03 | 90 | 93 | 3 | EFO_0004529, EFO_0004732 | |
| Disease | Antiglaucoma preparations and miotics use measurement | 3.04e-03 | 26 | 93 | 2 | EFO_0009944 | |
| Disease | Endogenous Hyperinsulinism | 3.04e-03 | 26 | 93 | 2 | C1257963 | |
| Disease | Exogenous Hyperinsulinism | 3.04e-03 | 26 | 93 | 2 | C1257964 | |
| Disease | Compensatory Hyperinsulinemia | 3.04e-03 | 26 | 93 | 2 | C1257965 | |
| Disease | Hypertensive disease | 3.11e-03 | 190 | 93 | 4 | C0020538 | |
| Disease | cholesteryl ester measurement, high density lipoprotein cholesterol measurement | 3.12e-03 | 312 | 93 | 5 | EFO_0004612, EFO_0010351 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| WANEKAWFQTPYTTF | 406 | Q9Y6F8 | |
| VWANEKAWFQTPYTT | 406 | Q9Y6F7 | |
| FYVEMKWEFTSWVPL | 121 | Q6ZTN6 | |
| WAQSWENIYDMVVPF | 286 | P12821 | |
| YWITEFWVMFKMDAS | 131 | O95267 | |
| VIYWLSNFVWDMCNY | 1696 | O95477 | |
| WNYSERTMMGYWSTQ | 791 | O95490 | |
| KFMEFYQDVKDWWLF | 246 | P25101 | |
| MQFYKTAKDWWLFSF | 266 | P24530 | |
| YKYEAPWTVYAMNWS | 11 | P61962 | |
| VEQQMYFWQYGHWTE | 821 | P58397 | |
| YKIHWWENVYGFDMS | 211 | Q99873 | |
| PSEWLSSVYKQQWFA | 356 | Q96IK5 | |
| MKGWQYRWFVLDYNA | 16 | Q96SU4 | |
| KPWWDVFTDYISIVM | 21 | Q8IWT6 | |
| WVVYTTEMNGKNTFW | 61 | Q9UI09 | |
| DFYVQMKWEFTSWVP | 121 | Q8IZ07 | |
| AQDFYVEMKWEFTSW | 126 | Q86YJ7 | |
| FWVESDNYFTVTKPW | 111 | Q5HYI7 | |
| DLKYVWLQGRQVWMY | 61 | P51606 | |
| KFYDENTRQWWMPDT | 736 | Q14703 | |
| ETKYLFQVGMWVWEA | 951 | Q6ZU64 | |
| KINVSYWCWEDMSPF | 861 | O75882 | |
| FEYKWWNTLPTNMET | 421 | Q6UXG2 | |
| KGGFDWNLVFKWDYM | 271 | Q10471 | |
| WNLVFKWDYMTPEQR | 276 | Q10471 | |
| EESYWWMQFTAAVEF | 1456 | Q14C86 | |
| WFSFTNPWTKELEYI | 451 | Q8WYA1 | |
| TRFDDWYLWVQMYKG | 291 | Q9BV94 | |
| TDCWTYHYSEKPMNW | 36 | P14151 | |
| YWSNWSNPAYTVVMD | 621 | P48357 | |
| CDIWYMRFSMDFWQK | 361 | O75530 | |
| SQSADWWSYGVLMFE | 251 | Q9UK32 | |
| MEGVLYKWTNYLSGW | 1 | Q96JA3 | |
| FDMWKDYFNLSQVVW | 6 | P60321 | |
| VWSTPQFWEAMFYGD | 676 | O95248 | |
| VWESSGQWMFSVYSP | 126 | O15504 | |
| WVVWIVMYTYGNKQH | 256 | Q9NQ84 | |
| YWWNANMVFIPYCSS | 171 | Q6P988 | |
| MSKGWYNLYETNWEV | 576 | Q9P2D7 | |
| WSGEFFTCNWKMKYV | 756 | A4FU69 | |
| YSVMWYWNRENSGSK | 846 | Q93033 | |
| YWFSNEMKSWSDSYV | 126 | Q9NZS2 | |
| WGYTSKWTNDYSMVL | 606 | Q16394 | |
| YQCITMEGWTDVLYW | 286 | Q13698 | |
| VMWEVMTYGERPYWE | 806 | P29317 | |
| INISYWGWEDMSPFT | 816 | Q5VV63 | |
| ETWTMKNVYNSWTYN | 141 | Q08334 | |
| NWMCYRKTEDFFTIW | 71 | P04180 | |
| WIQNWSFLKDYDPMG | 86 | Q96LR7 | |
| QPKMVMEYWTGWFDS | 271 | Q8IW92 | |
| LDENYFRGYEWWLMK | 121 | P54803 | |
| GQESYVWKMYQERCW | 5006 | P21817 | |
| VWKMYQERCWDFFPA | 5011 | P21817 | |
| YWMNDAMGFELPWVY | 371 | Q01668 | |
| EWSSTDVMNYFAWEK | 121 | Q6UW15 | |
| KFAWMDGSKVDYVSW | 871 | P22897 | |
| YIIWQNSTEDTWYKM | 146 | Q9BS40 | |
| HMVFNYGYLTWEWTE | 96 | Q92521 | |
| KFISMQNDFYWPWQI | 256 | P59536 | |
| DPWNWLDFSVIMMAY | 191 | P35499 | |
| SNWTYEFDKWAPSVV | 786 | P51531 | |
| DGQCYEYKWMASAWK | 1471 | Q9UPZ6 | |
| PSEWLSSVYKQQWFA | 356 | Q8NEA9 | |
| SNWAYEFDKWAPSVV | 816 | P51532 | |
| KVMSWWDYGYQITAM | 521 | P46977 | |
| TVTENKDGTYNWMSW | 301 | P78324 | |
| TVINYYTGWMQKWPT | 141 | Q9UIF7 | |
| LYPQFMESVWWVFKQ | 151 | P41252 | |
| MESVWWVFKQLYDKG | 156 | P41252 | |
| NWYRYEPSREMKSQW | 406 | Q9NRX5 | |
| LTENKDGTYNWMSWL | 301 | Q5TFQ8 | |
| WNYTFWQWFDGVMEV | 566 | P42229 | |
| WEKLSYMYGTICDIW | 1176 | Q8NFU7 | |
| MKWNGWGYNDSKFIF | 91 | O00116 | |
| VWASEKAWFQTPYAT | 371 | Q8N8U2 | |
| SEKQYFLRWMEWGLA | 561 | Q8TCY9 | |
| YVVMWKQVTQSYWDT | 1036 | P07996 | |
| KVWDDISPQFYATFW | 871 | Q8NI27 | |
| PHWSEEGTQWSLMYY | 341 | Q8N2C7 | |
| WQMYKKAEASFWTAE | 91 | P31350 | |
| MGIWCYTFAEMPWYQ | 211 | Q96DB5 | |
| AVTNCAMSYKGAWWY | 1286 | Q92752 | |
| YHTVWIPWNVFYVMD | 926 | Q9P273 | |
| WFGMWIFEEYFPMQT | 2621 | Q86WI1 | |
| TVKQSWDWTTDMDGY | 256 | Q9Y279 | |
| VLMAVFSDKGDYFWW | 131 | Q13336 | |
| MEGVLYKWTNYLTGW | 1 | Q9HB20 | |
| ISYQPGFWEMVKFAW | 256 | Q9H6L2 | |
| GFWEMVKFAWVQYVS | 261 | Q9H6L2 | |
| WNGKEFTAWYSDMET | 471 | O95361 | |
| FVWSYWKTIFTLPMN | 66 | Q9UIJ5 | |
| YRWQMLIGKTWTDFE | 536 | Q7Z2W4 | |
| WYFTEMVFCSRKWEQ | 136 | Q9NRZ5 | |
| EMDGYRFWKTGYWAS | 1366 | Q9NYU1 | |
| YHLQDYMFETLWKSW | 216 | P0DTE4 | |
| KEYNMYGWWVGELNS | 326 | Q86WV1 | |
| EMDGYRFWKSGYWAS | 1391 | Q9NYU2 | |
| KPWWDVFTDYLSVAM | 21 | Q8TDW0 | |
| STYLGDWYSVNWMED | 226 | Q99538 | |
| VYKEDYNNWMKGIGW | 1191 | P20929 |